NCT06762548View on ClinicalTrials.gov

Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 10, 2025

Primary Completion Date

September 11, 2026

Study Completion Date

November 6, 2026

Conditions
Chemotherapy Induced AlopeciaChemotherapy Side Effects
Interventions
DRUG

DA-007

Topical α1 agonist combination of Phenylephrine + Tyramine + Synephrine

DRUG

Placebo

Topical placebo solution

Trial Locations (1)

Unknown

"University of Rome (G. Marconi)", Rome

Sponsors
All Listed Sponsors
collaborator

Daniel Alain, Inc.

UNKNOWN

collaborator

Follea International Limited

INDUSTRY

lead

Applied Biology, Inc.

INDUSTRY